Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Do reactive oxygen species play a role in fighting COVID-19?

Serum-free thiols are known to reflect the activity of reactive oxygen species in the body, and researchers have been examining the difference in these thiols in COVID-19 patients.

21 Dec 2021

Scientists discover new autism biomarker in cerebrospinal fluid

Northwestern Medicine scientists have discovered a biomarker for one type of autism within patients' cerebrospinal fluid, according to a study published in the journal Neuron.

17 Dec 2021

Novel imaging method used to map glycosylation patterns linked with Alzheimer’s disease

Using new methodology, University of Kentucky researchers have mapped the variations in sugar chains attached to brain proteins from deceased healthy individuals or individuals with Alzheimer's disease.

15 Dec 2021

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Depixus®, a biotechnology company, today announces it has raised EUR 30.6 million in an oversubscribed Series A financing.

From Depixus® 15 Dec 2021

Thrombosis may increase mortality risk in hospitalized COVID-19 patients

A team of US-based scientists has recently explored various risk factors associated with the poor prognosis of coronavirus disease 2019 (COVID-19). They have identified thrombosis-related risk factors as a major predictor of in-hospital COVID-19 related mortality. The study is currently available on the medRxiv* preprint server while awaiting peer review.

14 Dec 2021

Increased troponin levels in the blood after surgery can be a sign of heart damage

After being anesthetized and undergoing major surgery, up to one in five patients have increased levels of the protein troponin in their blood. This can be a sign of heart damage.

14 Dec 2021

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

A new study published on the bioRxiv preprint server has hypothesized that T cell receptors (TCR) repertoire can measure the response to vaccines, as it would identify the TCR of clones that respond to the vaccination.

13 Dec 2021

Scientists describe dynamic genomic landscape of tumor heterogeneity in hepatocellular carcinoma

Clinician scientists and scientists from the National Cancer Centre Singapore and A*STAR's Genome Institute of Singapore, in collaboration with Singapore General Hospital, the National University Health System, Duke-NUS Medical School, Nanyang Technological University, and collaborators from China, Malaysia, Thailand and the Philippines, have described a dynamic genomic landscape of tumour heterogeneity in hepatocellular carcinoma (HCC).

13 Dec 2021

An assessment of COVID-19 mortality risk using patient biomarker time series

A new study discusses the use of multiple biomarkers taken over the course of hospitalization in COVID-19 patients to determine the risk of mortality.

12 Dec 2021

Potential association between senescence and aging in COVID-19

A review published in Cells discussed characteristics of cellular senescence and its potential role in COVID-19.

9 Dec 2021

Study identifies several proteins that protect against disease development

Inflammatory processes are associated with a large range of human diseases, including rheumatic diseases and allergies. Protein biomarkers are measurable molecules that can have a prognostic value in patients, be used to diagnose disease, or indicate severity of disease.

8 Dec 2021

Brain injury markers associated with dysregulated immunological responses in COVID-19

Study shows that during hospitalization, patients with COVID-19 demonstrated elevated NfL and GFAP in a severity-dependant manner, as well as evidence of ongoing active brain injury 4 months later.

8 Dec 2021

Canopy Biosciences launches the first of a series of targeted assay kits for ChipCytometry

Canopy Biosciences, a Bruker Company, today announced the launch of a first in a series of assay kits for ChipCytometry, a quantitative, high dynamic range and high-resolution multiplexing technology for spatial proteomics.

From Bruker Nano Surfaces and Metrology 8 Dec 2021

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

New findings have important implications for research into the impact of COVID-19 and the mRNA vaccination on epigenetic aging in the immune system.

7 Dec 2021

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Led by computational researchers from WEHI, in collaboration with The University of Queensland, Queensland University of Technology and Hospital Marcelino Champagnat in Brazil, the study used advanced spatial transcriptomic techniques to screen for genes associated with excessive inflammation in the lungs, a key indicator of severe COVID-19.

7 Dec 2021

Biomarker News and Research

Further Reading

Do reactive oxygen species play a role in fighting COVID-19?

Scientists discover new autism biomarker in cerebrospinal fluid

Novel imaging method used to map glycosylation patterns linked with Alzheimer’s disease

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Thrombosis may increase mortality risk in hospitalized COVID-19 patients

Increased troponin levels in the blood after surgery can be a sign of heart damage

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Scientists describe dynamic genomic landscape of tumor heterogeneity in hepatocellular carcinoma

An assessment of COVID-19 mortality risk using patient biomarker time series

Potential association between senescence and aging in COVID-19

Study identifies several proteins that protect against disease development

Brain injury markers associated with dysregulated immunological responses in COVID-19

Canopy Biosciences launches the first of a series of targeted assay kits for ChipCytometry

Epigenetic clocks have potential as biomarkers of COVID-19 vaccine responses

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Novel AI-based system models the progression of chronic diseases as patients age

Multiplex proteomic panel assay for assessment of disease severity and outcome prediction in COVID-19

Stand Up To Cancer - An Interview with Chris Draft

UC San Diego participates in the expansion of Parkinson’s Progression Markers Initiative

New marker could lead to better diagnoses of Covid-19

Industry Focus eBook - Protein Analysis (3rd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo